A carregar...
The art of the possible in approaching efficacy trials for COVID19 convalescent plasma
COVID-19 convalescent plasma (CCP) is widely used as a treatment. Although there are sufficient safety data, high-level evidence of efficacy is still lacking. We summarize here the results from randomized controlled trials (RCTs) published to date and analyze their flaws and biases. We then provide...
Na minha lista:
| Publicado no: | Int J Infect Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7836915/ https://ncbi.nlm.nih.gov/pubmed/33130197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.10.074 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|